Emage Fibroid Centers expands into Metro Detroit with Southfield open house

Emage Fibroid Centers opened its Metro Detroit practice in Southfield on Sept. 24 with an open house and ribbon cutting focused on uterine fibroid embolization, a nonsurgical treatment for fibroids. The expansion adds one of the region’s only outpatient centers specializing in UFE as demand grows for uterus-preserving care options.

Why it matters: - The Southfield opening adds another outpatient option for women in Metro Detroit who want to treat fibroids without surgery. - Emage Fibroid Centers says the expansion is aimed at improving access to uterine fibroid embolization, a treatment that preserves the uterus and can relieve heavy bleeding and pelvic pain. - Fibroids are common and can cause anemia, fatigue, fertility challenges and pregnancy complications.

What happened: - Emage Fibroid Centers—Detroit held an open house and ribbon cutting on Thursday, Sept. 24, 2026, to mark its expansion into Metro Detroit. - Community members toured the Southfield practice, met doctors and learned about uterine fibroid embolization, or UFE. - Emage Founder and Chief Medical Officer John Lipman, MD, FSIR, said the center is one of the only outpatient facilities specializing in UFE in Metro Detroit. - Southfield Mayor Kenson Siver welcomed the new practice and called the opening an investment in the city’s healthcare sector.

The details: - UFE works by blocking blood flow to fibroids, causing them to soften and shrink. - The procedure preserves the uterus while relieving symptoms such as heavy bleeding and pelvic pain. - The American College of Obstetricians & Gynecologists endorsed UFE in 2008. - Uterine fibroids are benign growths that develop in or on the uterus. - Fibroids affect up to 80% of Black women and 70% of white women by age 50. - Emage said women with fibroids are often told hysterectomy is their only option, even though most fibroids can be treated with UFE. - Emage—Detroit Medical Director Philip Adler, MD, said patients with years of heavy bleeding and abdominal or lower back pain have reported relief within weeks after UFE. - Emage also operates in Atlanta, Richmond, Va., and Washington, D.C. - More information is available on the company’s website.

Between the lines: - The opening reflects a broader push to make nonsurgical fibroid treatment more visible in a market where many patients may not know UFE exists. - The emphasis on outpatient care suggests Emage is positioning itself as an alternative to more invasive gynecologic procedures. - The presence of local officials signals the city sees healthcare expansion as part of economic development, not just a medical announcement.

What's next: - Emage is likely to use the Southfield site to expand awareness of UFE among Metro Detroit patients and referring clinicians. - The center’s broader network suggests Emage will keep building its footprint in major U.S. markets. - Patients seeking more treatment information can review the company’s online materials and schedule care through the new location.